Estradiol valerate and tibolone: Effects upon brain oxidative stress and blood biochemistry during aging in female rats

Biogerontology

Volumn 9, Issue 5, 2008, Pages 285-298

  Aguiar, R B ^a   Dickel, O E ^a   Cunha, R W ^a   Monserrat, J M ^a   Barros, D M ^a   Martinez, Pablo E ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

Aging; Antioxidant capacity; Estradiol; Lipid hydroperoxide; Reactive oxygen species; Tibolone

Indexed keywords

ESTRADIOL VALERATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; PRIMOGYNA; REACTIVE OXYGEN METABOLITE; TIBOLONE; TRIACYLGLYCEROL;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CHEMISTRY; BRAIN CORTEX; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HORMONE SUBSTITUTION; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 50649117321     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-008-9137-7     Document Type: Article

References (68)

1. Alexaki V-I, Charalampopoulos I, Kampa M, Nifli A-P, Hatzoglou A, Gravanis A, Castanas E (2006) Activation of membrane estrogen receptors induce pro-survival kinases. J Steroid Biochem Mol Biol 98:97-110
2. Ansell PJ, Espinosa-Nicholas C, Curran EM, Judy BM, Philips BJ, Hannink M, Lubahn DB (2004) In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Endocrinology 145(1):311-317
3. Badeau M, Adlercreutz H, Kaihovaara P, Tikkanen MJ (2005) Estrogen A-ring structure and antioxidative effect on lipoproteins. J Steroid Biochem Mol Biol 96:271-278
4. Bartus M, Lomnicka M, Lorkowska B, Franczyk M, Kostogrys RB, Pisulewski PM, Chlopicki S (2005). Hypertriglyceridemia but not hypercholesterolemia induces endothelial dysfunction in the rat. Pharmacol Rep 57:127-137
5. Bjarnason NH, Bjarnason K, Haarbo J, Bennink HJT, Christiansen C (1997) Tibolone: Influence on markers of cardiovascular disease. J Clin Endocrinol Metab 82(6):1752-1756
6. Bötner M, Wuttke W (2005) Chronic treatment with low doses of estradiol affects pituitary and thyroid function in young and middle-aged ovariectomized rats. Biogerontology 6:261-269
7. Burger HG, Dudley EC, Robertson DM, Dennerstein L (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257-275
8. Cagnacci A, Mallus E, Tuveri F, Cirillo R, Setteneri AM, Melis GB (1997) Effect of tibolone on glucose and lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 82(1):251-253
9. Celik O, Erdem G, Hascalik S, Karakas HM, Tamser M (2005) Magnetic resonance spectroscopic comparison of the effects of resveratrol (3,40,5-trihydroxy stilbene) to conjugated equine estrogen, tibolone and raloxifene on ovariectomized rat brains. Eur J Obstet Gynecol Reprod Biol 120(1):73-79
10. Cetinkaya MB, Alper T, Kokcu A, Yanik FF, Malatyalioglu E (2002) Tibolone versus four estrogen replacement therapy protocols and plasma lipid levels in postmenopausal women. Int J Gynecol Obstet 79:17-23
11. Chakraborty TR, Gore AC (2004) Aging-related changes in ovarian hormones, their receptors, and neuroendocrine function. Endocrinology 144:977-987
12. Chakraborty TR, Laurie NG, Gore AC (2003) Age-related changes in estrogen receptor β in rat hypothalamus: A quantitative analysis. Endocrinology 144:4164-4171
13. Chirstodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC (2006) Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the Atherogenic Index of Plasma. J Cardiovasc Pharmacol 47(4):542-548
14. de Gooyer ME, Deckers GH, Schoonen WGEJ, Verheul HAM, Kloosterboer HJ (2003) Receptor profiling and endocrine interactions of tibolone. Steroids 68:21-30
15. Dotan Y, Lichtenberg D, Pinchuk I (2004) Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43:200-227
16. Driver AS, Kodavanti PRS, Mundy WR (2000) Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol 22:175-181
17. Folmer V, Soares JCM, Rocha JBT (2002) Oxidative stress in mice is dependent on the free glucose content of the diet. Int J Biochem Cell Biol 34:1279-1285
18. Fridovich I (1998) Oxygen toxicity: A radical explanation. J Exp Biol 201:1203-1209
19. Garcia-Segura LM, Azcoitia I, DonCarlos LL (2001) Neuroprotection by estradiol. Prog Neurobiol 63:29-60
20. Genazzani AR, Bernardi F, Pluchino N, Giretti MS, Begliuomini S, Casarosa E, Luisi M, Kloosterboer HJ (2006) Effect of tibolone administration on central and peripheral levels of allopregnanolone and β-endorphin in female rats. Menopause 13(1):57-64
21. George O, Vallée M, Le Moal M, Mayo W (2006) Neurosteroids and cholinergic systems: Implications for sleep and cognitive processes and potential role of age-related changes. Psychopharmacology 186(3):402-413
22. Gibbs RB, Nelson D, Anthony MS, Clarkson TB (2002) Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomologous monkeys. Neuroscience 113(4):907-914
23. Godsland IF (2001) Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: Analysis of studies published from 1974-2000. Fertil Steril 75(5):898-915
24. Harman D (1984) Free radical theory of aging: The 'free radical' diseases. Age 7:111-131
25. Imai H, Nakagawa Y (2003) Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPX, GPX4) in mammalian cells. Free Radic Biol Med 34(2):145-169
26. Jin M, Jin F, Zhang L, Chen Z, Huang H (2005) Two estrogen replacement therapies differentially regulate expression of estrogen receptors alpha and beta in the hippocampus and cortex of ovariectomized rat. Mol Brain Res 142:107-114
27. Koh KK, Han SH, Shin M-S, Ahn JY, Lee Y, Shin EK (2005) Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: A randomized, double-blind, crossover study. Eur Heart J 26:1362-1368
28. Kuhl H (2001) Pharmacology of estrogens and gestagens. In: Fischl FH (ed) Menopause - andropause: Hormone replacement therapy through the ages. New cognition and therapy concepts. Krause & Pachernegg, Glabitz, pp 33-50
29. Kuhnz W, Putz B (1989) Pharmacokinetic interpretation of toxicity tests in rats treated with oestradiol valerate in the diet. Pharmacol Toxicol 65:217-222
30. Lee SY, Andoh T, Murphy DL, Chiueh CC (2003) 17β-Estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection. FASEB J 17:947-948
31. Linard A, Macaire J-P, Christon R (2001) Phospholipid hydroperoxide glutathione peroxidase activity and vitamin E level in the liver microsomal membrane: Effects of age and dietary alpha-linolenic acid deficiency. J Nutr Biochem 12(8):481-491
32. Liska DJ (1998) The detoxification enzyme systems. Altern Med Rev 3(3):187-198
33. Liu J, Mori A (1999) Stress, aging and brain oxidative damage. Neurochem Res 24(11):1479-1497
34. Manthey D, Behl C (2006) From structural biochemistry to expression profiling: Neuroprotective activities of estrogen. Neuroscience 138:845-850
35. Masoro EJ (2000) Caloric restriction and aging: An update. Exp Gerontol 35(3):299-305
36. Mattson MP, Duan W, Chan SL, Cheng A, Haughey N, Gary DS, Guo Z, Lee J, Furukawa K (2002) Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: Modification by genes, diet and behavior. Neurobiol Aging 23(5):695-705
37. Mertens A, Holvoet P (2001) Oxidized LDL and HDL: Antagonists in atherothrombosis. FASEB J 15:2073-2084
38. Mikkola TS, Anthony MS, Clarkson TB, St. Clair RW (2002) Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens. Metabolism 51(4):523-530
39. Monserrat JM, Geracitano LA, Pinho GL, Vinagre TM, Faleiros M, Alciati JC, Bianchini A (2003) Determination of lipid peroxides in invertebrate tissues using the Fe(III) xylenol orange complex formation. Arch Environ Contam Toxicol 45(2):177-183
40. Myhre O, Fonnum F (2001) The effect of aliphatic, naphthenic, and aromatic hydrocarbons on production of reactive oxygen species and reactive nitrogen species in rat brain synaptosome fraction: The involvement of calcium, nitric oxide synthase, mitochondria, and phospholipase A. Biochem Pharmacol 62(1):119-128
41. Niki E, Nakano M (1990) Estrogens as antioxidants. Methods Enzymol 186:330-333
42. Picazo O, Azcoitia I, Garcia-Segura LM (2003) Neuroprotective and neurotoxic effects of estrogens. Brain Res 990:20-27
43. 2 exposure. Pharmacol Biochem Behav 78:191-197
44. Regoli F, Winston GW (1999) Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Toxicol Appl Pharmacol 156(2):96-105
45. Rontu R, Solakivi T, Teisala K, Ki TL, Punnonen R, Jokela H (2004) Impact of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation. Free Radic Res 38(2):129-137
46. Sandhu SK, Kaur G (2002) Alterations in oxidative stress scavenger system in aging rat brain and lymphocytes. Biogerontology 3:161-173
47. Sharma PK, Thakur MK (2006) Expression of estrogen receptor (ER) α and β in mouse cerebral cortex: Effect of age, sex and gonadal steroids. Neurobiol Aging 27:880-887
48. Siqueira IR, Fochesatto C, de Andrade A, Santos M, Hagen M, Bello-Klein A, Netto CA (2005a) Total antioxidant capacity is impaired in different structures from aged rat brain. Int J Dev Neurosci 23:663-671
49. Siqueira IR, Fochesatto C, Torres IL, Da S, Dalmaz C, Netto CA (2005b) Aging affects oxidative state in hippocampus, hypothalamus and adrenal glands of Wistar rats. Life Sci 78:271-278
50. Sohal RS, Agarwal S, Sohal BH (1995) Oxidative stress and aging in the Mongolian gerbil (Meriones unguiculatus). Mech Ageing Dev 81:15-25
51. Stomati M, Bernardi F, Luisi S, Puccetti S, Casarosa E, Liut M, Quirici B, Pieri M, Genazzani AD, Luisi M, Genazzani AR (2002) Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: Effects on central and peripheral allopregnanolone and beta-endorphin. Maturitas 43(3):195-206
52. Storey KB (1996) Oxidative stress: Animal adaptations in nature. Braz J Med Biol Res 29(12):1715-1733
53. Strehlow K, Rotter S, Wassmann S, Adam O, Grohé C, Laufs K, Böhm M, Nickenig G (2003) Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93(2):170-177
54. Tan MH, Johns D, Glazer BN (2004) Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem 50:1184-1188
55. Thakur MK, Sharma PK (2006) Aging of brain: Role of estrogen. Neurochem Res 31:1389-1398
56. Thakur MK, Sharma PK (2007) Transcription of estrogen receptor α and β in mouse cerebral cortex: Effect of age, sex, 17β-estradiol and testosterone. Neurochem Int 50:314-321
57. Thibodeau BA, Kachadourian B, Lemay R, Bisson M, Day J, Paquette B (2002) In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem Mol Biol 81:227-236
58. Thomas JP, Maiorinog M, Ursinis F, Girotti AW (1990) Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation: In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 265(1):454-461
59. Tian L, Cai Q, Wei H (1998) Alterations of antioxidant enzymes and oxidative damage to macromolecules in different organs of rats during aging. Free Radic Biol Med 24(9):1477-1484
60. Timmer CJ, Houwing NS (2002) Dose proportionality of three different doses of tibolone. Pharmacotherapy 22:6-13
61. Turgeon JL, McDonnell DP, Martin KA, Wise PM (2004) Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304:1269-1273
62. Unfer TC, Conterato GMM, da Silva JCN, Duarte MMMF, Emanuelli T (2006) Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chim Acta 369(1):73-77
63. Vedder H, Anthes N, Stumm G, Würz C, Behl C, Krieg J-C (1999) Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem 72(3):2531-2538
64. Veiga S, Melcangi RC, Doncarlos LL, Garcia-Segura LM, Azcoitia I (2004) Sex hormones and brain aging. Exp Gerontol 39:1623-1631
65. von Eckardstein A, Nofer JR, Assmann G (2001) High density lipoproteins and arteriosclerosis: Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 21:13-27
66. Wojtal K, Trojnar MK, Czuczwar SJ (2006) Endogenous neuroprotective factors: Neurosteroids. Pharmacol Rep 58(3):335-340
67. Yoshitake K, Yokota K, Kasugai Y, Kagawa M, Sukamoto T, Nakamura T (1999) Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet. Bone 25(3):311-319
68. Zhang Y, Appelkvist E-L, Kristensson K, Dallner G (1996) The lipid compositions of different regions of rat brain during development and aging. Neurobiol Aging 17(6):869-875